Evolution of clinical trial endpoints in chronic myeloid leukemia: efficacious therapies require sensitive monitoring techniques.
Tibes, Raoul
Evolution of clinical trial endpoints in chronic myeloid leukemia: efficacious therapies require sensitive monitoring techniques. [electronic resource] - Leukemia research Jun 2012 - 664-71 p. digital
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't; Review
1873-5835
10.1016/j.leukres.2012.02.027 doi
Biomarkers, Tumor--analysis
Clinical Trials as Topic--trends
Endpoint Determination--trends
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--diagnosis
Medical Oncology--methods
Models, Biological
Monitoring, Physiologic--methods
Prognosis
Sensitivity and Specificity
Treatment Outcome
Evolution of clinical trial endpoints in chronic myeloid leukemia: efficacious therapies require sensitive monitoring techniques. [electronic resource] - Leukemia research Jun 2012 - 664-71 p. digital
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't; Review
1873-5835
10.1016/j.leukres.2012.02.027 doi
Biomarkers, Tumor--analysis
Clinical Trials as Topic--trends
Endpoint Determination--trends
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--diagnosis
Medical Oncology--methods
Models, Biological
Monitoring, Physiologic--methods
Prognosis
Sensitivity and Specificity
Treatment Outcome